Unfortunately, picoplatin fails to improve survival compared to supportive care in relapsed small cell #lungcancer: http://bit.ly/hxlJU

Related posts:

SPEAR trial of picoplatin for … SPEAR trial of picoplatin for pts w/relapsed small cell #lungcancer: disease ctr...

Picoplatin was also assoc’d w/… Picoplatin was also assoc’d w/sigif surv benefit for subgroup of pts. w/SCL...

Picoplatin also leads to impro… Picoplatin also leads to improvement in progression-free surv, but not overall surv...

SPEAR trial of $PARD agent pic… SPEAR trial of $PARD agent picoplatin vs. supportive care in relapsed SCLC completed...

Nexavar (sorafenib) fails to i… Nexavar (sorafenib) fails to improve survival in first line adv #lungcancer whe...